New cyclosporine derivative SDZ IMM 125: in vitro and in vivo pharmacologic effects and toxicologic evaluation.
Hiestand
P C
PC
Preclinical Research, Sandoz Pharmaceutical Ltd, Basel, Switzerland.
Gräber
M
M
Hurtenbach
U
U
Herrmann
P
P
Cammisuli
S
S
Richardson
B P
BP
Eberle
M K
MK
Donatsch
P
P
Ryffel
B
B
Borel
J F
JF
D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy; D016572:Cyclosporine / Q000494:pharmacology / Q000633:toxicity; D003524:Cyclosporins / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D007166:Immunosuppressive Agents / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D051381:Rats
D003524:Cyclosporins; D007166:Immunosuppressive Agents; D016572:Cyclosporine; C075935:SDZ IMM 125